Phosphatidlyinositol-3-Kinase C2 Beta (PI3KC2β) Is a Potential New Target to Treat IgE Mediated Disease

PLoS ONE - United States
doi 10.1371/journal.pone.0183474
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Mouse P170 Is a Novel Phosphatidylinositol 3-Kinase Containing a C2 Domain

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1996English

Treat to Target: A Proposed New Paradigm for the Management of Crohn's Disease

Clinical Gastroenterology and Hepatology
HepatologyGastroenterology
2015English

Aminoacylase 3 Is a New Potential Marker and Therapeutic Target in Hepatocellular Carcinoma

Journal of Cancer
Oncology
2018English

PI 3-Kinase Inhibition: A Therapeutic Target for Respiratory Disease

Biochemical Society Transactions
Biochemistry
2004English

Phosphoinositide-3 Kinase/Protein Kinase-B/Mammalian Target of Rapamycin Pathway in Psoriasis Pathogenesis. A Potential Therapeutic Target?

Acta Dermato-Venereologica
DermatologyMedicine
2014English

Phosphatidylinositol 3-Kinase-Δ (PI3K-δ) Is a Potential Therapeutic Target in Adult T-Cell Leukemia-Lymphoma

Biomarker Research
BiochemistryMolecular MedicineClinical Biochemistry
2018English

Protein Kinase D as a Potential New Target for Cancer Therapy

Biochimica et Biophysica Acta - Reviews on Cancer
Cancer ResearchOncologyGenetics
2010English

Objective Evaluation for Treat to Target in Crohn’s Disease

Journal of Gastroenterology
Gastroenterology
2020English

A New Blood Biomarker of Endoscopic Disease Activity: A Step Forward in the Treat-To-Target Paradigm for Crohn’s Disease?

Gastroenterology
HepatologyGastroenterology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy